Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-26

Clinical Trial Update: Acute Kidney Outreach to Reduce Deterioration and Death (AKORDD) [NA]

View source ↗

Summary

The AKORDD trial examined outreach strategies to reduce deterioration and death in patients with Acute Kidney Injury. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Heart of England NHS Trust | Conditions: Acute Kidney Injury | NA | Status: COMPLETED